Integrated Diagnostics Holdings plc
Market Cap
$340.08M
P/E Ratio
19.50
EPS
$0.03
Dividend Yield
2.74%
52-Week Range
$0.30 — $0.83
Volume
2.07K
Avg Volume
181.19K
Beta
0.28
P/E (TTM)
19.50
Forward P/E
0.20
PEG Ratio
0.94
P/S (TTM)
2.67
P/B (TTM)
5.78
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
0.38%
ROA (TTM)
0.15%
ROIC
—
Gross Margin
0.41%
Operating Margin
0.25%
Net Margin
—
Debt/Equity
0.43
Current Ratio
1.53
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.16%
EPS Growth (5Y)
+0.40%
Sales Growth (3Y)
+0.07%
Sales Growth (5Y)
+0.28%
EPS Est (This Year)
$2.86
EPS Est (Next Year)
$3.32
Dividend Yield
—
Annual Dividend
$0.02
Payout Ratio
—
Frequency
—
Ex-Dividend Date
2025-09-11
Cash/Share
$2.93
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
581.33M
Float
290.66M
Free Float %
50.00%
RSI (14)
43.53
SMA 20
$0.63
SMA 50
$0.67
SMA 200
$0.52
ATR (14)
0.04
Volatility (Week)
0.02%
Volatility (Month)
0.03%
Pattern
—
1 Day
-3.94%
1 Week
-2.40%
1 Month
-15.28%
3 Months
+8.93%
6 Months
+50.62%
1 Year
—
YTD
-14.08%
All-Time High
$0.83
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Country
JE
Exchange
LSE
IPO Date
2015-05-06
Employees
6309
CEO
Hend El Sherbini
Index Membership
—
Website
https://www.idhcorp.com
Integrated Diagnostics Holdings plc (IDHC.L) is a healthcare company in the medical - diagnostics & research industry listed on the LSE. With a market capitalization of $340.08M, a P/E ratio of 19.50, and a dividend yield of 2.74%, IDHC.L is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare IDHC.L against other stocks using dozens of fundamental and technical filters.
Integrated Diagnostics Holdings plc (IDHC.L) has a trailing twelve-month (TTM) P/E ratio of 19.50. This is near the market average range. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Integrated Diagnostics Holdings plc (IDHC.L) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Integrated Diagnostics Holdings plc (IDHC.L) has a market capitalization of $340.08 million, classifying it as a small-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Integrated Diagnostics Holdings plc (IDHC.L) has returned -14.08% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.